Back
Eliem Therapeutics Stock Price Chart
Sell
45
ELYM
Eliem Therapeutics
Last Price:
8.19
Seasonality Move:
-25.18%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is moderately bullish and ELYM is experiencing slight buying pressure.
Eliem Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.47 | Sell |
| 20-day SMA: | 7.18 | Buy |
| 50-day SMA: | 4.75 | Buy |
| 200-day SMA: | 3.18 | Buy |
| 8-day EMA: | 8.27 | Sell |
| 20-day EMA: | 7.35 | Buy |
| 50-day EMA: | 5.56 | Buy |
| 200-day EMA: | 3.73 | Buy |
Eliem Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.17 | Buy |
| Relative Strength Index (14 RSI): | 61.35 | Buy |
| Chaikin Money Flow: | 47362 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.31 - 8.93) | Buy |
| Bollinger Bands (100): | (1.71 - 5.79) | Buy |
Eliem Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Eliem Therapeutics Stock
Is Eliem Therapeutics Stock a Buy?
- Eliem Therapeutics share price is 8.25 while ELYM 8-day simple moving average is 8.47, which is a Sell signal.
- The stock price of ELYM is 8.25 while Eliem Therapeutics 20-day SMA is 7.18, which makes it a Buy.
- Eliem Therapeutics 50-day simple moving average is 4.75 while ELYM share price is 8.25, making it a Buy technically.
- ELYM stock price is 8.25 and Eliem Therapeutics 200-day simple moving average is 3.18, creating a Buy signal.
ELYM Technical Analysis vs Fundamental Analysis
Sell
45
Eliem Therapeutics (ELYM)
is a Sell
Is Eliem Therapeutics a Buy or a Sell?
-
Eliem Therapeutics stock is rated a Sell
The current Eliem Therapeutics [ELYM] share price is $8.25. The Score for ELYM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Eliem Therapeutics Stock Info
Market Cap:
240M
Price in USD:
8.25
Share Volume:
318.65K
Eliem Therapeutics 52-Week Range
52-Week High:
11.55
52-Week Low:
2.34
Sell
45
Eliem Therapeutics (ELYM)
is a Sell
Eliem Therapeutics Share Price Forecast
-
What is the Eliem Therapeutics stock price today?
The Eliem Therapeutics stock price is 8.25 USD today. -
Will ELYM stock go up or go down?
Eliem Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Eliem Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Eliem Therapeutics is overvalued.
Is Eliem Therapeutics Stock a Buy?
- Eliem Therapeutics share price is 8.25 while ELYM 8-day exponential moving average is 8.27, which is a Sell signal.
- The stock price of ELYM is 8.25 while Eliem Therapeutics 20-day EMA is 7.35, which makes it a Buy.
- Eliem Therapeutics 50-day exponential moving average is 5.56 while ELYM share price is 8.25, making it a Buy technically.
- ELYM stock price is 8.25 and Eliem Therapeutics 200-day simple moving average is 3.73, creating a Buy signal.
Technical Analysis of Eliem Therapeutics
Should I short Eliem Therapeutics stock?
- ELYM Moving Average Covergence Divergence (MACD) indicator is 1.17, suggesting Eliem Therapeutics is a Buy
- Eliem Therapeutics Relative Strength Index (RSI) is 61.35, which suggest Eliem Therapeutics is overbought
- The Bollinger Bands (25) for Eliem Therapeutics is (4.31 - 8.93), which suggest Eliem Therapeutics is a Buy
- The Bollinger Bands (100) for Eliem Therapeutics is (1.71 - 5.79), which suggest Eliem Therapeutics is a Buy
* Eliem Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.